Why Oppenheimer Global fund is focusing on biotech as rates rise

Wed, 28 Feb 2018 - 07:51 GMT

Biotechs will see little impact from rising interest rates because investors are more focused on the long-term potential of their drugs, said Rajeev Bhaman.